- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | One dose of AZ's COVID-19 vaccine 'highly effective' against severe disease from variants | ||
| Fr | The future of work has been just around the corner for some time... | ||
| Fr | Roche engaged in talks with FDA for Alzheimer's drug candidate | ||
| Fr | Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader | ||
| Do | Langland promotes Jake Davis to managing partner | ||
| Do | Novartis sees demand returning to pre-COVID-19 levels in Q2 results | ||
| Do | Merck, Eisai's Keytruda/Lenvima regimen scores full approval in endometrial cancer | ||
| Do | Paving the way for the HCP omnichannel experience: a guide for medical affairs | ||
| Do | J&J, distributors reach $26bn settlement to address the opioid crisis in the US | ||
| Mi | EU approves bluebird bio's CALD gene therapy Skysona | ||
| Mi | NHS earmarks £340m for new medicines fund to fast-track 'innovative' treatments | ||
| Mi | EMA begins rolling review of Sanofi, GSK's COVID-19 vaccine | ||
| Mi | The Chronicles of Pharma: a creative review of pharma's journey to omnichannel | ||
| Di | BioNTech plans acquisition of Kite's TCR cell therapy R&D platform | ||
| Di | AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront | ||
| Di | Bayer's BlueRock Therapeutics gains FDA fast track for Parkinson's disease cell therapy | ||
| Mo | Kriya Therapeutics raises $100m to further develop gene therapies with 'broader applications' | ||
| Mo | GSK reveals plans for £400m R&D facility expansion in England | ||
| Mo | Lilly and Banner Alzheimer's Institute collaborate on donanemab prevention trial | ||
| 16.07. | FDA advisory committee votes against approval of AZ, FibroGen's roxadustat | ||
| 16.07. | Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery | ||
| 16.07. | UK's CMA fines drugmakers £260m for overcharging NHS for steroid med | ||
| 15.07. | Ogilvy Health appoints Rebecca Carter to newly created head of social media role | ||
| 15.07. | Ashfield launches 'end-to-end' cell and gene therapy commercialisation network | ||
| 15.07. | British officials reportedly monitoring Philip Morris' proposed acquisition of Vectura |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
